Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/43085
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorÚsuga Úsuga, Franky Alberto-
dc.contributor.authorVelásquez Lopera, Margarita María-
dc.contributor.authorQuiros Gómez, Oscar Iván-
dc.contributor.authorCorrea Londoño, Luis Alfonso-
dc.date.accessioned2024-11-03T13:16:59Z-
dc.date.available2024-11-03T13:16:59Z-
dc.date.issued2019-
dc.identifier.issn0926-9959-
dc.identifier.urihttps://hdl.handle.net/10495/43085-
dc.description.abstractABSTRACT: Psoriasis affects the individual, their social and family environment (1,2), comorbidity with human immunodeficiency virus (HIV) could worsen its clinical presentation, an underlying cause of this shame are dysregulation and immunosuppression (3). It has been postulated that gp120 HIV glycoprotein acts as superantigen that activate CD4+ cells, Bcells, and basophils, even it could stimulate expression HLA-DR in keratinocyte, a feasible mechanism for HIV to cause psoriasis in previously non-psoriatic individuals (3). The prevalence of psoriasis-HIV is between 2.5% to 5%. Psoriasis can be the initial cutaneous manifestation of an HIV infection, and it is present during all phases of disease including AIDS. Vulgar, guttate and erythrodermic psoriasis are most frequently associated with HIV (3). Objectives: To describe the clinical and histopathological characteristicsspa
dc.format.extent2 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherWileyspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleClinical and histopathological characteristics of HIV-psoriasis casesspa
dc.typeinfo:eu-repo/semantics/conferenceObjectspa
dc.publisher.groupCentro de de Investigaciones Dermatológicasspa
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1468-3083-
oaire.citationtitleJournal of the European Academy of Dermatology and Venereologyspa
oaire.citationstartpage59spa
oaire.citationendpage60spa
oaire.citationvolume33spa
oaire.citationissueSuplemento 3spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.publisher.placeOxford, Inglaterraspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6670spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ECspa
dc.type.localPóster de conferenciaspa
dc.subject.decsPsoriasis-
dc.subject.decsHistología-
dc.subject.decsHistology-
dc.subject.decsVIH-
dc.subject.decsHIV-
dc.description.researchgroupidCOL0130733spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D011565-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D006653-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D006678-
dc.relation.ispartofjournalabbrevJ. Eur. Acad. Dermatol. Venereol.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
UsugaFranky_2019_Clinical_Histopathological.pdfPóster de conferencia149.5 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons